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ABSTRACT
Objective: Species of Erythrina variegata L. is reported to be used in the treatment of cancer in traditional/folklore medicine which could be explored 
for their anticancer potential. We aimed to evaluate the anticancer activity of crude extracts of the leaves of E. variegata with two solvents; explore the 
mechanism of cytotoxicity with the effective extract and correlation with the phytochemicals in the extract.
Methods: The extracts with Erythrina variegata L methanol (EVM) and chloroform (EVC) as solvents were screened for cytotoxicity by 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium assay on MDA-MB-231 and MCF-7 cell lines. The effective extract was further evaluated on 
MDA-MB-231 cells by nucleoprotein content estimation, and cell morphology was studied. High resolution liquid chromatography mass spectrometry 
(HRLCMS) of EVM was done to find the phytochemical composition.
Results: Among the two extracts, EVM was effective at an inhibitory concentration (IC50) value of 92 µg/ml and 143 µg/ml on MCF-7 and 
MDA-MB-231 cells, respectively. At the IC50 value (143 µg/ml) the nucleoprotein content of the cells was 58.2%, and the apoptotic index was 
calculated to be 51.8%. EVM treated group showed significant morphological changes suggestive of apoptosis. HRLCMS revealed the presence of 
rutin, podocarpatriene, and cepharanthine which are known to be cytotoxic.
Conclusion: This report is a contribution toward the validation of E. variegata as a potential source of anticancer agents.
Keywords: Erythrina variegata, Cytotoxicity, Apoptosis, MDA-MB-231, Podocarpatriene.
INTRODUCTION
Cancer is a common cause for mortality, standing second after 
cardiovascular disorders, and an over looming threat to mankind [1,2]. 
In developing countries like India, breast cancer is highly prevalent 
and in years to come the numbers may increase alarmingly due to 
environmental pollution, changes in lifestyle and inclusion of genetically 
modified food in the diet [3]. The histology of breast cancer shows a 
heterogeneous population of cells and like any cancer, the development 
is regulated by a large number of genes as well [4,5]. Therefore 
compounds that arrest the cell cycle, suppress cell proliferation, induce 
cell death and/or activate apoptosis would be ideal for the treatment 
of cancer [6-11].
Plants are an important source of therapy for human ailments. 
Worldwide and more so in India, there are a number of tribal/ethnic 
groups who have a vast knowledge of the use of plants in therapy. 
The “ethnomedicinal studies” of the therapeutic values of these 
plants involve a systematic scientific evaluation [12]. A number of 
ethnomedicinal species have been identified in families’ such as 
Apiaceae, Brassicaceae, Fabaceae, Rutaceae, and Zingiberaceae for the 
treatment of cancer [13]. In particular, family Fabaceae contains species 
such as Phaseolus vulgaris L., Glycine max L., Vigna unguiculata, Cajanus 
cajan (L.) Millsp. (Pigeon pea), and Arachis hypogaea which have 
exhibited cytotoxic effects on tumor/cancer cells [13]. The anticancer 
properties of members of Fabaceae have been traced to the presence 
of phytochemicals such as isoflavones genistein, anthocyanins, 
b-sitosterol, and resveratrol.
Erythrina variegata L. (Family, Fabaceae) also known as a coral tree is a 
medicinal plant that is widely distributed in the tropical and subtropical 
regions of the world. The plant has a wide range of properties one 
of them being cytotoxicity [14]. The leaves and roots from this plant 
are reported to be used in the Chinese herbal medicine for treatment 
of cancer [15]. Erythrina species have also been reported to be used 
in folk medicine against stomach cancer [16]. Although the plant is 
being used in alternative medicines for cancer, very few investigations 
have evaluated the mechanism of action. The chloroform and carbon 
tetrachloride partitionates of the methanolic extract of the bark of 
E. variegata L (EVM). are shown to be cytotoxic [17]. The phytochemical 
analysis of the Soxhlet methanol extracts of the bark has also exhibited 
cytotoxicity [18]. In this study, crude extracts of the leaf powder of 
E. variegata L., in two solvents, prepared by a very simple extraction 
procedure, have been screened for their cytotoxic efficacy and the more 
effective of the two extracts has been studied further for evaluation of 




The leaves of E. variegata were collected from Mangalore, Karnataka, 
Dakshina Kannada district of Karnataka, India, and were identified and 
authenticated by Dr. Noeline J. Pinto, Taxonomist, St. Agnes College, 
Mangalore, Karnataka, India. A voucher specimen (SAC/BOT-15/104) 
was submitted at the herbarium for future reference.
Preparation of extracts
Leaves of E. variegata L. were collected, washed with distilled water, 
shade dried and cut into small pieces. These dried samples were 
powdered using a mixer grinder. Extracts (10% w/v) were made at 
room temperature, using two solvents, i.e., methanol and chloroform 
with intermittent shaking for 24 hrs. The extracts were filtered through 
Whatman no. 1 and the clear filtrate was evaporated to dryness to form 
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methanol soluble (EVM) and chloroform soluble (EVC) extracts and 
stored at 4°C until further use.
Cell lines
MCF-7 michigan cancer foundation-7; non-metastatic origin and 
MDA-MB-231 (MD Anderson Series); metastatic origin procured 
from National Centre for Cell Sciences, Pune, India, were cultured 
in Dulbecco’s Modified Eagle Medium supplemented with, 10% 
heat-inactivated fetal bovine serum, 2 mM L-glutamine, penicillin 
(100 IU/ml), streptomycin (100 μg/ml), and amphotericin-B (5 µg/ml) 
in humidified atmosphere of 5% CO2 at 37°C. The cells were trypsinized 
with 0.25% trypsin-ethylenediaminetetraacetic acid solution. The 
stock cultures were grown in 25 cm2 flat bottles, and the cell viability 
studies were conducted in 96 well microtiter plates.
Cytotoxicity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo 
lium (MTT) assay
Cells were seeded in 96 well flat bottom microtiter plates at a density of 
5×104 cells per well for MTT assay [19,20] and were cultured at 37°C, 
in 5% CO2 atmosphere, for 24 hrs, to allow cell adhesion. After 24 hrs, 
when partial monolayers were formed, cells were treated with different 
concentrations of either the standard drug (doxorubicin/cisplatin) 
(0.62 µg/ml, 1.25 µg/ml, 2.5 µg/ml, 5 µg/ml, and 10 µg/ml) or 
the extracts (31.25 µg/ml, 62.5 µg/ml, 125 µg/ml, 250 µg/ml, and 
500 µg/ml) and further incubated for 48 hrs. Post-treatment, 100 µl 
of freshly prepared MTT (1 mg/ml phosphate buffered saline [PBS]) 
was added to each well. The plates were shaken gently and incubated at 
37°C in 5% CO2 atmosphere for 4 hrs. After 4 hrs, the supernatant was 
removed, and the formazan crystals formed in the cells were solubilized 
by addition of 100 µl of dimethyl sulfoxide. The absorbance was read 
using a microplate reader (Bio-Tek, ELX-800 MS) at 570 nm. The assay 
was done in triplicate for each of the extracts.
The percentage growth inhibition was calculated using the formula 
below:
% growth inhibition = [(control absorbance - test absorbance)/(control 
absorbance)] ×100
A graph was plotted with concentration of standard drug/extract 
on x-axis and absorbance on the y-axis. From this curve, inhibitory 
concentration (IC50) (concentration of drug required to kill 50% of cells 
in exponentially growing cultures after a 48 hrs exposure to the drug) 
values were calculated. The most effective extract was used for further 
studies with MDA-MB-231 cell line.
Nucleoprotein content assay with MDA-MB-231
The assay was performed as the procedure given by Gillies et al., 1986 [21]. 
Cells were seeded in 96 well flat bottom microtiter plates at a density of 
1×105 cells per well and were cultured at 37°°C, in 5% CO2 atmosphere, 
for 24 hrs, to allow cell adhesion. MDA-MB-231 cells were treated with 
varying concentrations of either the standard drug (cisplatin) (0.5 µg/ml, 
1.0 µg/ml, and 2 µg/ml) or the extracts (12.5 µg/ml, 25 µg/ml, 50 µg/ml, 
100 µg/ml, and 200 µg/ml) for 48 hrs. After the treatment, the medium 
was aspirated, and the cells were washed with PBS. The cells were then 
fixed in 4% formaldehyde for 30 minutes. The nucleoprotein content of 
the fixed cells was stained with crystal violet (0.1%) for 60 minutes and 
then destained by multiple washes with distilled water. The plates were 
left overnight for air drying. Remaining crystal violet was solubilized in 
100x dilution of glacial acetic acid (0.1 ml). Absorbance was measured 
at 590 nm and read using a microplate reader (BMG Labtech, Fluostar 
Omega V3.00R2). The nucleoprotein content was calculated as follows:
% nucleoprotein content = [(control absorbance - test absorbance)/
control absorbance)] ×100.
Morphological detection of apoptosis
Morphological detection of apoptosis was studied using acridine orange 
and Giemsa stains as described earlier [22]. Cells were seeded in a 6 well 
microtiter plate at a density of 5×105 cells per well and cultured at 37°C, 
in 5% CO2 atmosphere, for 24 hrs. After 24 hrs, medium was removed, 
and cells were exposed to different concentrations of the standard drug 
(cisplatin: 0.5 µg/ml) and the crude extracts (50 µg/ml, 150 µg/ml, and 
250 µg/ml) for 48 hrs. Post-treatment, the cells were collected, washed 
and suspended in PBS (pH 7.4). 100 µl of the cell suspension was used 
for acridine orange staining (1 mg/ml). After staining, the cells were 
observed for morphological features of apoptosis under a fluorescent 
microscope (Olympus CX41) and photographed. Viable cells stain 
green, early apoptotic cells stain yellow and late apoptotic cells appear 
reddish orange. 200 cells were counted for each data point, and the 
apoptotic index was calculated as [number of apoptotic cells/total cells 
counted] ×100.
For Giemsa staining: Cells were treated with diluted Giemsa (1 in 
20 ml Sorenson’s buffer) after fixation (methanol:acetic acid) and 
were observed under a light microscope for morphological features 
of apoptosis such as membrane blebbing, nuclear fragmentation, 
chromatin condensation, and apoptotic bodies.
Qualitative screening for phytochemicals
The phytochemical analysis was performed with the EVM. 
Qualitative analysis was peformed to detect the presence/absence of 
phytochemicals such as alkaloids by Wagner’s test and Hager’s test; 
flavonoids by alkaline reagent test and lead acetate test; tannins and 
phenols by ferric chloride test and gelatin test; saponins by foam test; 
carbohydrates by Molisch’s test and Benedict’s test; amino acids by 
ninhydrin test and proteins by biuret test, glycosides by Keller–Killiani 
test, and bromine water test; steroids and terpenoids by Salkowski’s 
test and Liebermann Burchard’s test, according to the standard 
procedures [23].
Quantitative analysis of phytochemicals
Quantitative analysis of the EVM. was performed according to the 
standard procedures [23]. The total flavonoid content was determined 
by aluminum chloride colorimetric technique. Steroids were estimated 
by Liebermann-Burchard’s reaction method. Alkaloids, tannins, and 
saponins were estimated according to the standard procedures [23]. 
The samples were analyzed in triplicates (n=3), and the results were 
expressed as mean ± standard deviation (SD) values.
High resolution liquid chromatograph mass spectrometer 
(HRLCMS) analysis
HRLCMS of the EVM was done using a quadrupole time-of-flight 
(TOF/Q-TOF) mass spectrometer (Agilent Technologies, USA) at Indian 
Institute of Technology, Bombay. Mass spectrometer was carried out in 
positive and negative ionization mode with a mass/charge ratio ranging 
from 50 to 1000. 2 µl of the sample was used for the analysis. Elution 
was done using a solvent gradient of acetonitrile:water (80:20 v/v) 
with a flow rate of 0.3 ml/minutes for 30 minutes.
Statistical analysis
Data were expressed as mean ± SD values of triplicate experiments 
(n=3). Analysis was performed using one-way ANOVA followed by least 
significant difference post hoc test for comparison between control and 
treatment groups. Comparisons of the number of viable and apoptotic 
cells, in the various treated and untreated groups were done by 
Chi-square analysis using SPSS version 14 software (IBM). p<0.05 was 
considered to be statistically significant.
RESULTS AND DISCUSSION
This study is an attempt to assess the cytotoxic effects of the leaf extracts 
of E. variegata and associate the activity with the phytochemical 
composition of the extract as well as validate its use in the traditional 
medicine [16]. Among the extracts prepared from two solvents, 
i.e., methanol and chloroform, the extractive yield of E. variegata leaves 
was maximum in methanol (13.3% w/w) followed by chloroform 
(5.2% w/w). In the preliminary screening, the crude EVM leaves 
obtained by cold maceration method showed significant cytotoxicity 
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with IC50 values of 92±1.8 µg/ml and 143.0±3.4 µg/ml for MCF-7 and 
MDA-MB-231 cells, respectively. However, the chloroform soluble 
extracts did not show effective cytotoxicity against MDA-MB-231 (IC50 
value: 365.0±2.5 µg/ml) and MCF-7 cells (IC50 >500 µg/ml). Cisplatin and 
doxorubicin (positive controls) gave an IC50 value of 0.5±0.13 µg/ml and 
1.09±0.03 µg/ml against MDA-MB-231 and MCF-7 cells, respectively, by 
MTT assay (Fig. 1). Statistical analysis, shows that the cytotoxicity of 
the EVM was significant (p<0.001) than chloroform soluble extracts on 
both the cell lines (Table 1). Unlike an earlier report involving sensitivity 
of genistein (10 µM), an isoflavonoid molecule, on six different breast 
cancer cell lines, which has shown differences in the sensitivity of 
genistein between cell lines. In this study there were small differences 
in the IC50 values of the EVM between the two breast cancer cell lines 
(p>0.05) (Table 1). This may be suggestive of a common mechanism 
of growth modulation by the extract in both the cell lines which are 
genetically/phenotypically different [24]. Hence, further studies for 
the mechanism for cytotoxicity were conducted on MDA-MB-231 cells, 
which are triple receptor negative cells, with methanol soluble (EVM) 
extracts.
The earlier reports from the in vitro studies of extracts of the stem 
bark of E. variegata were also with methanol as solvent by Soxhlet 
extraction in which the phytochemical was purified and identified 
to be erystagallin A, molecule of isoflavonoid nature, that had an 
IC50 value of 3.3 µg/ml against T47D breast cancer cell line [25]. Yet 
another report of an in vivo study using methanol extract of the root 
bark of E. variegata has shown decrease in the numbers of cancer 
cells, packed cell volume and increase in tumor weight and survival 
time of the animals, clearly indicating the presence of the anticancer 
activity of the methanol extracts of the root bark as well [15]. The 
study has not speculated on the phytochemical responsible for the 
cytotoxic effect, and there was a difference in the procedure for extract 
preparation which involved successive extraction with petroleum ether 
and methanol. The dichloromethane: methanol soluble whole plant 
extract of Erythrina lysistemon, another species from the same genus, 
has shown cytotoxicity with 15% growth inhibition and the anticancer 
effect was attributed to the presence of phytochemicals [26].
The cytotoxicity of the drug can be measured in terms of cell 
viability, nucleoprotein content, cell proliferation, cell cycle analysis, 
etc. [27]. A decrease in the nucleoprotein content clearly suggests 
extract/drug induced cell detachment/decreased cell proliferation. 
EVM appear to show a dose dependent decrease in live cells as shown 
in the nucleoprotein content. At the IC50 values derived from MTT assay 
(143 µg/ml) the survival rate of the cells was 58.2%, while at a higher 
dose (200 µg/ml) of the extract, the viability of the cells decreased. 
Cisplatin, the positive control has also shown a similar dose-dependent 
decrease in nucleoprotein content (Fig. 2). A similar effect was seen by 
the action of docetaxel, anticancer drug, on MDA-MB-231 cells, and the 
mechanism of action was apoptosis [27].
Staining with acridine orange (Fig. 3) showed the presence of viable 
cells with green fluorescence, early apoptotic cells was yellow in color 
and late apoptotic cells appeared reddish orange. In the treatment 
groups, significant morphological changes such as cell shrinkage and 
Table 1: IC50 values of control and crude extracts of E. variegata 
against MCF-7 and MDA-MB-231 cells




Methanol extract (EVM) 143.0±3.4* 92±1.8*
Chloroform extract (EVC) 365.0±2.5 >500
The IC50 values were determined from the cell viability curve at 50% 
after 48 hrs of treatment and expressed as µg/ml. Data are represented 
as mean±SD (n=3); *statistical significance p<0.001 between control 
versus treatment groups, E. variegata: Erythrina variegata, IC50: Inhibitory 
concentration
Fig. 1: Effect of Erythrina variegata methanol and chloroform crude extracts on MDA-MB-231 and MCF-7 cells by MTT assay with cisplatin 
and doxorubicin (positive control). Methanol soluble extract (EVM), chloroform soluble extract (EVC). The inhibitory concentration values 
determined from the graph at 50% cell death after 48 hrs of treatment
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reduced cell density were observed compared to the normal cells that 
stained green with large and clear intact nucleus (Fig. 3).
When stained with Giemsa (Fig. 4), characteristic markers of apoptosis 
such as chromatin condensation, membrane-bound apoptotic bodies, 
fragmented nuclei, plasma membrane blebbing, membrane disruption 
were observed. These results suggest that the mechanism of action in 
cells treated with EVM was apoptosis.
There was an increase in the percentage of apoptotic cells with the 
increase in concentrations of the extract (Fig. 5). The calculated 
apoptotic index in the extract treated groups was 32% at 50 µg/ml, 
56% at 150 µg/ml, and 82% at 250 µg/ml of EVM. In the cisplatin 
treated group, the apoptotic index was found to be 80% at an IC50 value 
(0.5 µg/ml). Apoptotic index at an IC50 value of 143 µg/ml was calculated 
from the curve plotted with concentration of EVM on the X axis and 
apoptotic index on the Y axis and was found to be 51.8%. Apoptotic 
index of treated cells was significantly different from untreated cells 
(p<0.001). Chemotherapeutic agents are known to induce cytotoxicity 
by apoptosis [28]. Plant extracts have diverse groups of phytochemicals, 
each having its own mechanism of action with the final outcome being 
apoptosis [29,30]. It has been suggested in earlier reports that since 
MCF-7 cells are caspase 3 deficient, the cytotoxicity may be due to a 
caspase 3 independent mechanism, such as activation of other caspases 
which when activated result in chromatin condensation or cell death in 
the extract treated cells [9].
Table 2: Concentration of the phytochemicals (% w/w) in the 
methanol soluble leaf extracts of E. variegata L.







E. variegata: Erythrina variegata
Fig. 2: Effect of varying concentrations of (a) methanol soluble crude leaf extract of E. variegata (EVM) and (b) positive control (cisplatin) 
on nucleoprotein content of MDA-MB-231 cells. Values are mean ± SD (n=3)
ba
Fig. 3: Microphotography of MDA-MB-231 cells stained with acridine orange (a) viable cells (b) early apoptotic cells (c) late apoptotic cells 
(magnification of the picture - 20x and inset 40x)
cba
Fig. 4: Microphotography (magnification: 40x) of 
MDA-MB-231 cells stained with Giemsa (a) viable cells, 
(b) membrane disruption, (c and f) membrane blebbing, 
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Preliminary phytochemical screening of the EVM by qualitative tests 
was positive for flavonoids, alkaloids, tannins, phenols, saponins, 
carbohydrates, glycosides, steroids and terpenoids, and negative for 
proteins. The results of the quantitative estimation of the chemical 
constituents - flavonoids, tannins, steroids, saponins, and alkaloids 
are summarized in Table 2. The quantitative analysis revealed highest 
concentrations of flavonoids (92.57±2.4% w/w), followed by tannins, 
steroids, saponins, and alkaloids. The role of phytochemicals such as 
flavonoids, alkaloids, and terpenoids in cancer chemoprevention and 
chemotherapy has been reported [31]. Flavonoids are known to have 
cytotoxic effects, and the presence of flavonoids such as rutin has been 
reported by the HRLCMS data.
The chemical profile of EVM by HRLCMS showed the presence of 
three compounds with reported cytotoxicity, i.e., Rutin, 3a-hydroxy-4, 
4-bisnor-8, 11, 13-podocarpatriene, and cepharanthine (Table 3). In 
another study, the methanol extracts of the stem bark of E. variegata 
have revealed the presence of compounds such as 6-hydroxygenistein, 
3b, 28-dihydroxyolean-12-ene, epilupeol and stigmasterol belonging 
to the triterpenoids and steroid groups of compounds and exhibiting 
varying degrees of cytotoxicity [18]. A terpenoid pentacyclic glycoside 
has been isolated from the leaves of E. variegata which has shown to be 
cytotoxic on breast cancer cell line T47D [25].
Rutin is a glycoside of quercetin. It is shown to have antimutagenic 
action and is an inhibitor of carcinogenic process and a potential 
cancer preventive agent. Members of the broad flavonoid family 
have exhibited a wide variety of anticancer effects acting as 
antioxidants, angiogenesis inhibition, and potent cytotoxic agents [32]. 
Podocarpatrienes are cytotoxic diterpenoids that have been reported 
from Podocarpus madagascariensis, Jatropha species which have 
been used in the treatment for leukemia [33]. Cepharanthine, a plant-
derived alkaloid, has proven to have anticancer activity on murine P388 
doxorubicin - sensitive (P388/S) and - resistant (P388/DOX) cells. The 
mechanism of action has been studied to be apoptosis [34].
In conclusion, methanol appears to be a good solvent for extraction of 
anticancer principle from the leaves of E. variegata. The mechanism of 
Table 3: Anticancer components detected in the methanol soluble leaf extracts of E. variegata by HRLCMS
Name of the compound RT Molecular formula Molecular mass
Rutin 20.9 C27H30O16 610.15
3α-hydroxy-4,4-bisnor-8,11,13-Podocarpatriene 0.8 C15H20O 216.15
Cepharanthine 21.5 C37H38N2O6 606.27
Arachidonoylmorpholine 8.8 C24H39NO2 373.30
E. variegata: Erythrina variegata, HRLCMS: High resolution liquid chromatograph mass spectrometer, HRLCMS conditions: Mobile phase: Acetonitrile: Methanol  
(gradient elution), detector: UHPLC PDA detector; flow rate: 0.3 ml/minutes; injection volume: 2 µl; run time: 30 minutes. MS ESI (positive and negative mode 
ionization, m/z from 50 to 1000)
cell death appears to be apoptosis. HRLCMS of the methanol soluble 
crude extract showed the presence of rutin (phenol), podocarpatriene 
(terpenoid), cepharanthine (an alkaloid), that are known for cytotoxic 
activity. This preliminary study validates the traditional use of 
E. variegata L. in the treatment for cancer.
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